$CVM
Cel-Sci Corporation
XASE•Health Care•Biological Products, (No Diagnostic Substances)
$1.94
▼-0.51%-$0.010
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateCel-Sci Corporation
XASE•Health Care•Biological Products, (No Diagnostic Substances)
Flagged at $2.43 at 04:47 AM on Oct 06, then ran to $2.83 +16% that session.
The high is the session peak after our first alert, not a realized trade. Not investment advice.
Why is CVM down today? It is at $1.94 (-0.51%), and our scanner flagged it 27 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CVM spikes, and full due diligence on CVM — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $CVM 27 times in the last 30 days. Create a free account to track $CVM, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on CVM from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CVM today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystShareholder Vote, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Oct 1, 2026 · 8 days agoAcross every filing on file, supply equal to 17.3% of the tradeable float is in play - 17.3% has already been sold.
Recent priced share offering — a one-time sale that has already completed (not ongoing)
2,500,000 new shares · About $18.1M in size · Priced at $1/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Kersten Geert R Officer | Acquired (grant/award) | +3K 0.01% of company | added 0.8% | 319K | $5K at $2.06 | Sep 30, 26 |
Prichep Patricia B Officer | Acquired (grant/award) | +2K 0.01% of company | added 12% | 20K | $4K at $2.06 | Sep 30, 26 |
Talor Eyal Officer | Acquired (grant/award) | +1K | added 13% | 10K | $2K at $2.06 | Sep 30, 26 |
Kersten Geert R Officer | Bought (open market) | +100K 0.6% of company | added 46% | 316K | $138K at $1.38 | Aug 25, 26 |
Kersten Geert R Officer | Acquired (grant/award) | +5K 0.03% of company | added 2.5% | 216K | $5K at $1.04 | Jun 30, 26 |
Prichep Patricia B Officer | Acquired (grant/award) | +4K 0.02% of company | added 31% | 17K | $4K at $1.04 | Jun 30, 26 |
Talor Eyal Officer | Acquired (grant/award) | +2K 0.01% of company | added 33% | 9K | $2K at $1.04 | Jun 30, 26 |
Kersten Geert R Officer | Bought (open market) | +300K 1.7% of company | added 100% | 312K | $360K at $1.20 | May 14, 26 |
Kersten Geert R Officer | Bought (open market) | +100K 0.6% of company | added 82% | 222K | $119K at $1.19 | May 13, 26 |
Kersten Geert R Officer | Acquired (grant/award) | +2K | added 1.4% | 122K | $5K at $3.21 | Mar 31, 26 |
Prichep Patricia B Officer | Acquired (grant/award) | +1K | added 11% | 13K | $4K at $3.21 | Mar 31, 26 |
Talor Eyal Officer | Acquired (grant/award) | +747 | added 12% | 7K | $2K at $3.21 | Mar 31, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on CVM from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CVM today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
CVM last traded at $1.94, down 0.51% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The CVM Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CVM 27 times in the last 30 days.
CVM (Cel-Sci Corporation) trades on XASE, with a market cap of about $34M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CVM for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$CVM discussion
Sign in to ask a question or join the discussion.